NDC11 57894016001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 57894-0160-01 | 57894-0160 |
| 57894-0160-1 | 57894-0160 |
| 57894-160-01 | 57894-160 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INFLIXIMAB | INFLIXIMAB | Janssen Biotech, Inc. | b05c174f-832c-4321-b34f-2c4ad3742269 | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | 57894-160-01 57894-160 57894016001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.